21 employees
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
2019
$11M
from 3 investors over 3 rounds
FoRx Therapeutics raised $11M on April 22, 2020
Investors: Omega Funds, M Ventures and EQT Life Sciences